Skip to main content
MedCap logo

MedCap — Investor Relations & Filings

Ticker · MCAP ISIN · SE0009160872 LEI · 549300NGO5XAJ6TL8719 ST Financial and insurance activities
Open in API
Filings indexed 167 across all filing types
Latest filing 2018-02-23 Interim / Quarterly Rep…
Country SE Sweden
Listing ST MCAP

About MedCap

https://medcap.se/en/

MedCap is an investment company that acquires and develops profitable, market-leading niche companies within the life science sector. The group's strategy focuses on long-term ownership of small and medium-sized enterprises, primarily in Northern Europe, with potential for international growth. Operations are organized into three business areas: MedTech, Assistive Tech, and Specialty Pharma. MedCap supports its portfolio companies by providing capital, expertise, experience, and networks to foster their development and expansion.

Recent filings

Filing Released Lang Actions
Interim / Quarterly Report 2017
Interim / Quarterly Report Classification · 1% confidence The document is a 'Bokslutskommuniké' (Year-end report/Interim report) for MedCap AB, covering the period May 2017 to December 2017. It contains detailed financial statements, including income statements, cash flow data, segment analysis, and management commentary on performance. It is a comprehensive financial report for a period shorter than a full fiscal year (due to a change in the fiscal year-end), fitting the definition of an Interim/Quarterly Report (IR). H2 2017
2018-02-23 Swedish
MedCap fokuserar på två affärsområden efter strategisk översyn. Nedskrivning av goodwill om 13 MSEK relaterad till affärsområde Läkemedelshandel.
Earnings Release Classification · 1% confidence The document is a press release dated January 29, 2018, announcing a strategic refocusing by MedCap AB, including a goodwill impairment of 13 MSEK related to discontinuing the 'Läkemedelshandel' (Drug Trade) business area. It discusses changes in business focus, financial implications (impairment), and capital structure elements (working capital financing). This type of announcement, detailing strategic shifts and non-routine financial adjustments outside of standard quarterly/annual reporting, often falls under general regulatory announcements or capital/financing updates. Since it details a significant strategic change and a non-cash financial event (impairment) resulting from a strategic decision, it is best classified as a Capital/Financing Update (CAP) or potentially a Regulatory Filing (RNS) if no better fit exists. Given the focus on strategic restructuring and the resulting goodwill write-down, CAP is a strong candidate, as it relates to the capital structure/strategy. However, the text explicitly states it is information MedCap is obliged to disclose under the EU Market Abuse Regulation (MAR), which points towards a general regulatory disclosure. Since 'CAP' covers financing activities and strategic capital structure changes, and this involves a write-down related to a business segment change, I will lean towards CAP, as it is more specific than RNS. If the focus was purely on the impairment without the strategic context, RNS might be better, but the strategic pivot is central. Given the options, CAP covers strategic financial restructuring well. Q4 2017
2018-01-29 Swedish
Valberedning i MedCap utsedd
AGM Information Classification · 1% confidence The document is a press release dated January 11, 2018, announcing the composition of the Nomination Committee ('Valberedning') for the upcoming Annual General Meeting (AGM) in 2018. The nomination committee's role is to propose candidates for the board, auditors, and remuneration for the AGM. This content directly relates to the preparation and governance surrounding the AGM, specifically concerning board nominations and structure, which falls under Governance Information (CGR) or potentially AGM-related material. Since it details the structure and function of the committee responsible for proposing board members and governance matters for the AGM, CGR (Governance Information) is a strong fit, as it covers internal rules and board structure. However, given the context of preparing for the AGM, it is closely related to AGM procedures. Comparing CGR and AGM-R: AGM-R is for presentations/materials *during* the AGM. This document is a pre-AGM announcement about the committee that *prepares* proposals for the AGM. CGR covers governance practices and board structure, which includes the nomination process. Given the focus on the composition of the body responsible for board nominations, CGR is the most precise fit among the options for governance structure preparation, although it is a very specific type of governance announcement. Since it is an announcement about the structure of a key governance body preparing for the AGM, CGR is selected over AGM-R (which implies the meeting itself) or RNS (which is a fallback).
2018-01-11 Swedish
MedCap förvärvar Strässle i Tyskland
M&A Activity Classification · 1% confidence The document is a press release dated December 22, 2017, announcing that MedCap AB has signed an agreement to acquire the German company Strässle & Co. Medizintechnik GmbH. The text details the strategic value, financial terms (cash payment and potential earn-out), financing method, and expected closing date of the acquisition. This clearly falls under the category of announcing a significant corporate transaction, specifically a merger or takeover proposal/activity. Therefore, the appropriate classification is M&A Activity (TAR). The document is short and is an announcement, not the final regulatory filing for the transaction itself.
2017-12-22 Swedish
Interim / Quarterly Report 2017
Interim / Quarterly Report Classification · 1% confidence The document is titled 'DELÅRSRAPPORT' (Interim Report) for MedCap AB, covering the period August 2017 – October 2017. It contains detailed financial statements, including income statements, balance sheet data, cash flow information, and management commentary on business segments. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). Q2 2017
2017-11-30 Swedish
Extra Bolagsstämma MedCap den 6 november 2017
AGM Information Classification · 1% confidence The document is a press release dated November 6, 2017, titled "Extra Bolagsstämma MedCap den 6 november 2017" (MedCap's Extraordinary General Meeting held on November 6, 2017). It details a resolution passed at this meeting concerning the acquisition of shares in Inpac Aircontainer Holding AB. Since the document reports on decisions made at a General Meeting (specifically an Extraordinary General Meeting, EGM), and the available codes include AGM-R (AGM Information) and DVA (Declaration of Voting Results & Voting Rights Announcements), I must choose the most appropriate one. While it relates to a meeting, it primarily reports the *outcome* or *decision* made, which aligns closely with DVA, which covers official results from shareholder votes at any general meeting. However, the text describes the *event* and the *decision* taken, which is often covered by AGM-R if it's the material presented or summarized from the meeting itself, or DVA if it's strictly the vote tally. Given the context of reporting a key resolution from an EGM, and the lack of specific voting percentages, AGM-R (AGM Information) is a strong candidate for summarizing meeting outcomes, but DVA specifically covers 'Official results from shareholder votes'. Since this is a press release summarizing a key decision from an EGM, and DVA is defined as covering results from shareholder votes, I will lean towards DVA as it is a formal announcement of a decision reached by the shareholders/meeting. If the document were the full minutes or voting results, DVA would be certain. Given the content is a summary of a key resolution passed at an EGM, DVA is the most precise fit among the options for reporting meeting outcomes/decisions.
2017-11-06 Swedish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.